Fractional Flow Reserve Market Projected to reach $1,082 million by 2024 | Key players include Abbott (US), Boston Scientific (US), ACIST Medical Systems (US)

Fractional Flow Reserve Market by Technology (Invasive Monitoring, Non-invasive Monitoring), Invasive Monitoring Product (Pressure Guidewires, FFR Measurement Systems), Application, and Region - Global Forecast to 2024

The Research Report on Fractional Flow Reserve Market Growth is attributed to the rising geriatric population and the subsequent growth in the prevalence of cardiovascular diseases, cost benefits of FFR, and the presence of a favorable reimbursement scenario for FFR.

Growth is largely driven by the increasing geriatric population and the subsequent growth in the prevalence of cardiovascular diseases, cost-benefits of FFR, and the presence of a favorable reimbursement scenario. Emerging economies are expected to present market players with a wide range of opportunities.

The research report segments the Fractional Flow Reserve market based on Technology & Product, type, Application, and region.

Download PDF (FFR Industry):https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=257837023

Market Size Estimation -

Top-down and bottom-up approaches were used to validate the size of the fractional flow reserve market and estimate the size of other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The industry’s market size, in terms of value, was determined through primary and secondary research processes.
  • All percentage shares splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Fractional Flow Reserve Market Based on Technology;

On the basis of technology, the market is segmented into invasive and non-invasive monitoring. The invasive monitoring segment accounted for the largest share of the market in 2018. The large share of this segment can be attributed to the strong recommendation for FFR usage in coronary angiography by the American College of Cardiology, American Heart Association, European Society of Cardiology (ESC), and the European Association for Cardio-Thoracic Surgery (EACTS).

Fractional Flow Reserve Market Based on Type;

On the basis of type, the invasive monitoring market is segmented into pressure guidewires and FFR monitoring systems. The pressure guidewires segment accounted for the larger market share in 2018. This can be attributed to the growth in the number of PCI procedures (as a result of the rising prevalence of CVD), strong recommendation for guided revascularization by measuring FFR in specific clinical scenarios, and the single-use nature of pressure guidewires.

On the basis of Application, the fractional flow reserve market has been segmented as follows:

  • Single-vessel Diseases
  • Multi-vessel Diseases

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=257837023

North America is the major revenue-generating region in the fractional flow reserve market. The fractional flow reserve market in the region is driven by high healthcare spending in the region, rising prevalence of CVD and lifestyle diseases, growth in the geriatric population, a large number of ongoing research activities and product launches, availability of reimbursements, and the rapid adoption of technologically advanced imaging systems.

Key Market Players —

The key players in the fractional flow reserve market are Abbott (US), Boston Scientific (US), ACIST Medical Systems (US), Koninklijke Philips N.V. (Netherlands), Opsens, Inc. (Canada), HeartFlow, Inc. (US), Siemens Healthineers (Germany), Pie Medical Imaging (Netherlands), CathWorks (Israel), and Medis Medical Imaging Systems BV (Netherlands).

Abbott (US) held the leading position in the fractional flow reserve market. The company acquired a significant share in the FFR market through the acquisition of St. Jude Medical (US). This acquisition positioned Abbott as a major cardiology devices provider. The strategic acquisition of St. Jude Medical, a leading player in the cardiovascular and neuromodulation products market, strengthened the position of Abbott in the fractional flow reserve market. Abbott focuses on continuous expansions to achieve optimal growth across industries and different geographic areas.